Lord Kamall Alert Sample


Alert Sample

View the Parallel Parliament page for Lord Kamall

Information between 1st June 2025 - 1st July 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Speeches
Lord Kamall speeches from: Care Workers: Foreign Worker Visas
Lord Kamall contributed 1 speech (129 words)
Wednesday 18th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Learning Disabilities Nursing
Lord Kamall contributed 1 speech (88 words)
Tuesday 17th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025
Lord Kamall contributed 1 speech (592 words)
Tuesday 17th June 2025 - Grand Committee
Department of Health and Social Care
Lord Kamall speeches from: Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025
Lord Kamall contributed 2 speeches (1,001 words)
Tuesday 17th June 2025 - Grand Committee
Department of Health and Social Care
Lord Kamall speeches from: Adult Social Care
Lord Kamall contributed 1 speech (114 words)
Monday 16th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Cardiovascular Illnesses
Lord Kamall contributed 1 speech (1,127 words)
Thursday 12th June 2025 - Grand Committee
Department of Health and Social Care
Lord Kamall speeches from: Primary and Community Care
Lord Kamall contributed 1 speech (71 words)
Thursday 5th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Creon
Lord Kamall contributed 2 speeches (149 words)
Thursday 5th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Young Children: Convenience Foods
Lord Kamall contributed 1 speech (124 words)
Wednesday 4th June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Health: Ultra-processed Food
Lord Kamall contributed 1 speech (199 words)
Tuesday 3rd June 2025 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: European Convention on Human Rights: Protocol 12
Lord Kamall contributed 1 speech (42 words)
Monday 2nd June 2025 - Lords Chamber
Ministry of Justice


Written Answers
Doctors: Training
Asked by: Lord Kamall (Conservative - Life peer)
Monday 30th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many individual applicants have applied for medical speciality training places across all 65 specialities in 2025, and how many training places are available.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold this information as the 2025 medical specialty recruitment process is still ongoing.

Medical Records
Asked by: Lord Kamall (Conservative - Life peer)
Monday 30th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government what are the Health Data Research UK projects that access NHS data where specific project independent review was not received from NHS England's Advisory Group for Data, and what is the current status of those projects.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England has a Data Sharing Agreement, project identification code DARS-NIC-381078-Y9C5K, with a consortium of academic organisations in the United Kingdom for the purpose of the Health Data Research UK-led, British Heart Foundation Data Science Centre’s CVD-COVID-UK programme.

This agreement was put in place by NHS Digital prior to its merger with NHS England in 2023, and prior to the establishment of NHS England’s Advisory Group for Data (AGD). The AGD was informed of a Senior Information Risk Owner decision to approve an amendment to the agreement on 22 February 2024.

The agreement was subject to reviews by NHS Digital’s Independent Group Advising on the Release of Data (IGARD) on 25 June 2020, 23 July 2020, 15 October 2020, 3 December 2020, 25 February 2021, 29 July 2021, 29 July 2021, 5 May 2022, and 24 November 2022. It was also subject to advice from the Professional Advisory Group on 24 June 2020 and 28 July 2021.

The agreement allowed the data controllers under that agreement to approve access to National Health Service data for individual projects, subject to approval per project by the CVD-COVID-UK oversight committee, which included a representative of NHS Digital/NHS England. Individual projects were not reviewed by IGARD or the AGD.

Under the terms of the agreement, the CVD-COVID-UK oversight committee is required to maintain a list of projects undertaken under the agreement and provide a quarterly report to NHS Digital/NHS England. The following table lists the projects and their current status from the latest report provided in April 2025:

Secure Data Environment research project reference

Current project status

Project title

CCU001

Live - Data in Use

Investigating the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 outcomes

CCU002

Live - Data in Use

SARS-CoV-2 infection and vaccination and the risk of vascular events

CCU003

Live - Data in Use

Direct and indirect effects of the COVID-19 pandemic in individuals with cardiovascular disease (CVD)

CCU004

Live - Data in Use

COVID-19 and CVD risk prediction

CCU005

Live - Data in Use

Data management and analysis methods

CCU007

Live - Data in Use

Impact of COVID-19 pandemic on heart disease patients undergoing cardiac surgery

CCU008

Completed

Evaluating impact of COVID-19 pandemic on the prevalence and management of risk factors

CCU010

Live - Data in Use

In people with CVD and COVID-19, what is the influence of multi-morbidity on risk of poorer outcomes?

CCU013

Live - Data in Use

High-throughput electronic health record phenotyping approaches

CCU014

Live - Data in Use

Assessing the impact of COVID-19 on clinical pathways using a medicines approach

CCU018

Live - Data in Use

COVID-19 infection during pregnancy on CVD and related risk factors

CCU019

Live - Data in Use

Identification and personalised risk prediction for severe COVID-19 in patients with rare disorders impacting cardiovascular health

CCU020

Completed

Evaluation of antithrombotic use and COVID-19 outcomes

CCU022

Live - Data in Use

Genomics of multimorbidity and CVD associated with susceptibility to COVID-19 infection and complications

CCU023

Live - Data in Use

Repurposing medicines used to treat CVD risk to prevent COVID-19

CCU024

Completed

CovPall-Connect. Evaluation of how palliative and end of life care teams have responded to COVID-19: Connecting to boost impact and data assets

CCU028

Live - Data in Use

Coronary revascularisation and outcomes before and after the COVID-19 pandemic

CCU029

Live - Data in Use

Child hospital admission with COVID-19: risk factors; risk groups; and NHS care utilisation

CCU030

Live - Data in Use

Examining potential factors underlying the increased risk of severe COVID-19 experienced by people with intellectual and developmental disabilities

CCU032

Live - Data in Use

The effects of COVID-19 on heart failure subtypes

CCU035

Completed

Are people with COVID-19 and pre-existing respiratory disease at a higher risk of future cardiovascular and venous thromboembolic events compared with COVID-19 patients without pre-existing respiratory disease?

CCU036

Live - Data in Use

The impact of previous exposure to COVID-19 and the safety of COVID-19 vaccination for fertility and pregnancy outcomes

CCU037

Live - Data in Use

Improving methods to minimise bias in ethnicity data for more representative and generalisable models, using CVD in COVID-19 as an example

CCU038

Live - Data in Use

Evaluating the impact of COVID-19 on critical care outcomes

CCU040

Completed

Investigating why some people with diabetes have a greater risk of becoming seriously unwell or dying with COVID-19

CCU043

Live - Data in Use

Investigating new onset diabetes following COVID-19 infection

CCU045

Live - Data in Use

The impact of COVID-19 on heart failure epidemiology, quality of care and outcomes across primary and secondary care

CCU046

Live - Data in Use

Severe mental illness and receipt of acute cardiac care and mortality following myocardial infarction

CCU049

Live - Data in Use

Healthcare utilisation in individuals with Long COVID

CCU051

Completed

Un-vaccination and under-vaccination against SARS-CoV-2 in the UK

CCU052

Live - Data in Use

An observational retrospective cohort study describing the changing epidemiology pre, during and post COVID-19 of asthma, interstitial lung disease, and chronic obstructive pulmonary disease in England

CCU053

Live - Data in Use

Risks and benefits of treatment with SGLT2 inhibitors and the impact of intercurrent illness with COVID-19

CCU056

Completed

Socio-demographic make-up of patients undergoing surgical and transcatheter aortic valve intervention in England and the impact of COVID-19 on this

CCU057

Live - Data in Use

Risks for mortality in people with severe mental illnesses during the COVID-19 pandemic

CCU058

Live - Data in Use

COVID-19 impact on the long-term outcomes of Improving Access to Psychological Therapies in people with long-term cardiovascular conditions

CCU059

Completed

Which combinations of multiple long-term conditions are associated with the greatest risk of hospital admission over the winter season, and to what extent does COVID-19 or influenza vaccination modify this risk?

CCU060

Live - Data in Use

Improving characterisation, prediction and intervention for COVID-19 and influenza-related morbidity and mortality

CCU063

Live - Data in Use

The effect of COVID-19 on maternal and paediatric health among individuals whose first language isn’t English and require an interpreter in England: from preconception to adolescence

CCU064

Live - Data in Use

Impact of COVID-19 clinical care pathway changes on gestational diabetes incidence and pregnancy outcomes in England

CCU066

Live - Data in Use

Changes in acute cardiac care of patients with reduced kidney function during the COVID-19 pandemic

CCU068

Completed

The impact of vaccination on the excess clinical risks of COVID-19 in patients with congenital heart disease

CCU069

Live - Data in Use

RARE-CVD-COVID: To understand COVID-19 impact on intersectional disparity in rare versus common cardiometabolic diseases: CVD and metabolic diseases, including diabetes

CCU070

Live - Data in Use

Supporting novel trial designs using healthcare systems data to mitigate the impact of COVID-19 on diabetes research

CCU071

Live - Data in Use

A regional approach for policy makers to tackle health inequalities in CVD and its risk factors

CCU072

Live - Data in Use

Influence of COVID-19 on British burden of CVD

CCU073

Live - Data in Use

Impact of COVID-19 on the association between Type 2 diabetes and incidence of CVD

CCU074

Live - Data in Use

Improving the accuracy, equity and efficiency of using healthcare systems data for recruitment to a clinical trial involving people with CVD and diabetes mellitus: a simulation study in the “Covid era” using the CVD‑COVID‑UK dataset

CCU075

Live - Data in Use

Impact of the COVID-19 pandemic on corticosteroid use and side effects in Takayasu arteritis and ANCA-associated vasculitis in England

CCU076

Live - Data in Use

The effect of COVID-19 infection on cardiovascular outcomes: an interaction analysis with environmental exposure

CCU077

Live - Data in Use

Risk assessment and long-term outcomes of acute coronary syndrome management strategy in cardio-oncology patients before and after the COVID-19 era

CCU078

On hold

Foresight: a generative artificial intelligence model of patient trajectories across the COVID-19 pandemic

CCU079

Live - Data in Use

Investigating the diagnoses of conditions among children in England following SARS-CoV-2 infections compared to general respiratory infections

CCU080

Live - Data in Use

Impact of COVID-19 on the use of cardiovascular imaging

CCU081

Live - Data in Use

Investigating the impact of COVID-19 on cardiovascular and thromboembolic events in idiopathic inflammatory myopathies and the incidence of connective tissue diseases

CCU082

Live - Data in Use

Pulmonary arterial hypertension in repaired congenital heart disease: impact of the COVID-19 pandemic on prevalence; late diagnosis; and outcomes

CCU083

Live - Data in Use

Trends in choice of management strategy for NSTE-ACS among patients with previous bypass surgery before and after the COVID-19 pandemic

CCU084

Live - Data in Use

Impact of COVID-19 on stroke incidence, severity, aetiology, management, and outcome in younger versus older individuals in England

CCU085

Live - Data in Use

STROKE-IMPACT: What are the long-term consequences of stroke on the patient and to the NHS, and how does COVID-19 contribute to variation?

CCU086

Live - Data in Use

A data landscape review of datasets used in the surveillance of neurological complications of COVID-19

CCU087

Live - Data in Use

The impact of COVID-19 on heart failure outcomes: the moderation roles of diabetes and obesity

CCU088

Live - Data in Use

The impact of COVID-19 on the management of iron deficiency, with or without anaemia, in primary and secondary care

CCU089

Live - Data in Use

The impact of comorbidity, socioeconomic status, and ethnicity on waiting times for surgery before and after the COVID-19 pandemic

CCU090

Live - Data in Use

The impact of cardiac rehabilitation following transcatheter aortic valve implantation before and after the COVID-19 pandemic

CCU092

Live - Data in Use

Simulation modelling of CVD development and management, identifying the extent to which COVID-19 has impacted on the assessment and treatment of CVD.

CCU093

Live - Data in Use

Understanding the relationship between diabetes and the development of multiple long-term conditions in England, Scotland, and Wales during and after the COVID-19 pandemic

CCU094

Live - Data in Use

Identifying preventative opportunities for coronary heart disease and stroke in multi-ethnic patients with non-cardiovascular conditions including COVID-19

CCU095

Live - Data in Use

Quantifying and mitigating bias and health inequalities induced by clinical risk models predicting COVID-19-related risks of people with CVD and diabetes.

CCU096

Live - Data in Use

Impact of COVID-19 on obesity and risks of cardio-renal-metabolic outcomes

CCU097

Live - Data in Use

Drivers, consequences and the COVID-19 pandemic’s effect on severe hyperglycaemia at type 2 diabetes diagnosis

CCU100

Live - Data in Use

Impact of COVID-19 on fatty liver disease and cardiovascular outcomes in England, across ethnicities and social deprivation

CCU101

Live - Data in Use

Lung-Pal-Equity: To identify patterns in use of hospital services in the last year of life for those with advanced lung disease and to examine inequalities by socio-economic group, including before, during and after the COVID-19 pandemic


The status of project CCU078 has been updated to reflect that NHS England paused the project on 29 May. Further detail on the projects is published on the British Heart Foundation Data Science Centre’s website.

NHS: Databases
Asked by: Lord Kamall (Conservative - Life peer)
Friday 20th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government what discussions they have had with Health Data Research UK about projects that used NHS England’s data for pandemic planning and research without disclosure to a Professional Advisory Group or NHS England's Advisory Group for Data.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England has a Data Sharing Agreement, project code DARS-NIC-381078-Y9C5K, with a consortium of academic organisations in the United Kingdom for the purpose of the Health Data Research UK-led, British Heart Foundation Data Science Centre’s CVD-COVID-UK programme. This agreement was put in place by NHS Digital prior to its merger with NHS England in 2023.

The agreement was subject to reviews by NHS Digital’s Independent Group Advising on Release of Data on 25 June 2020, 23 July 2020, 15 October 2020, 3 December 2020, 25 February 2021, 29 July 2021, 5 May 2022, and 24 November 2022. It was also subject to advice from the Professional Advisory Group on 24 June 2020 and 28 July 2021.

As part of the agreed process, all projects undertaken under this agreement required approval by the CVD-COVID-UK Approvals and Oversight Board. NHS Digital/NHS England had a representative on that board and through this decision-making forum, engaged in discussions with Health Data Research UK about projects that used NHS England’s data for pandemic planning and research.

For a project to proceed, approval was required from the NHS Digital/NHS England representative and from the board as a whole. Under the terms of the agreement, the CVD-COVID-UK oversight committee is required to maintain a list of projects undertaken under the agreement and must provide a quarterly report to NHS Digital/NHS England.

Subsequently, concerns have been raised by the Royal College of General Practitioners and the British Medical Association in relation to the Foresight project which was undertaken under the above agreement. NHS England has confirmed to the Royal College of General Practitioners and the British Medical Association that NHS England’s Data Protection Officer is undertaking assurance, and NHS England has met operationally with others, including Health Data Research UK, in relation to this work.

General Practitioners: Data Processing
Asked by: Lord Kamall (Conservative - Life peer)
Friday 20th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the general practice extraction service data for pandemic planning and research is being used for any direct care decisions.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The General Practice Extraction Service Data for Pandemic Planning and Research is not being used for direct care decisions.

Junior Doctors: Training
Asked by: Lord Kamall (Conservative - Life peer)
Wednesday 4th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many resident doctor trauma and orthopaedics training places were offered by each integrated care board in England in 2023–24 and 2024–25.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold data on medical specialty training places by integrated care board, but is able to present data by National Health Service training region. The following table shows the number of trauma and orthopaedics specialist training posts available in the 2023 and 2024 entry rounds by region:

Region

2023 round posts

2024 round posts

East Midlands

19

11

East of England

18

11

Kent, Surrey and Sussex

15

17

London

20

36

North East

6

8

North West

16

13

South West

13

13

Thames Valley

3

3

Wessex

7

10

West Midlands

13

17

Yorkshire and the Humber

13

14

Total

143

153

Source: NHS England, available on the NHS.UK website, in an online only format.

The table presents the number of posts offered at specialist training stage three, meaning medical professionals will already have undertaken at least two years of relevant core training or equivalent before entry to this specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 

We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.

Junior Doctors: Training
Asked by: Lord Kamall (Conservative - Life peer)
Wednesday 4th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many resident doctor paediatric training places were offered by each integrated care board in England in 2023–24 and 2024–25.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold data on medical specialty training places by integrated care board, but is able to present data by National Health Service training region. The following table shows the number of paediatric specialist training posts available in the 2023 and 2024 entry rounds by region:

Specialist training stage one

Specialist training stages three and four

Region

2023 round posts

2024 round posts

2023 round posts

2024 round posts

East Midlands

32

32

14

7

East of England

42

31

6

n/a

Kent, Surrey and Sussex

18

25

n/a

4

London

107

107

24

15

North East

19

19

2

1

North West

47

42

9

8

South West

26

28

18

4

Thames Valley

20

16

4

2

Wessex

14

16

n/a

n/a

West Midlands

36

37

6

2

Yorkshire and the Humber

56

59

18

5

Total

417

412

101

48

Source: NHS England, available at the NHS.UK website, in an online only format.

The table presents the number of posts offered at both specialist training stage one, and at stages three or four. The latter stages mean that the medical professionals will likely have already undertaken at least three or four years of relevant training, or an equivalent, before entry to this later stage of the specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 

We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.

Junior Doctors: Training
Asked by: Lord Kamall (Conservative - Life peer)
Wednesday 4th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many resident doctor medical oncologist training places were offered by each integrated care board in England in 2023–24 and 2024–25.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold data on medical specialty training places by integrated care board, but is able to present data by National Health Service training region. The following table shows the number of medical oncology specialist training posts available in the 2023 and 2024 entry rounds by region:

Region

2023 round posts

2024 round posts

East Midlands

5

4

East of England

7

11

Kent, Surrey and Sussex

8

8

London

11

19

North East

4

1

North West

11

10

South West

8

6

Thames Valley

4

5

Wessex

5

2

West Midlands

8

5

Yorkshire and the Humber

7

6

Total

78

77

Source: NHS England, available on the NHS.UK website, in an online only format.

The table presents the number of posts offered at specialist training stage three, meaning medical professionals will already have undertaken at least two years of relevant core training or the equivalent, before entry to this specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 

We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.

Junior Doctors: Training
Asked by: Lord Kamall (Conservative - Life peer)
Wednesday 4th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many resident doctor gynaecologist training places were offered by each integrated care board in England in 2023–24 and 2024–25.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department does not hold data on medical specialty training places by integrated care board but is able to present data by National Health Service training region. Data is only available for the combined obstetrics and gynaecology specialist training pathway, as opposed to specifically gynaecology specialist training. The following table shows the number of obstetrics and gynaecology specialist training posts available in the 2023 and 2024 entry rounds by region:

Specialist training stage one

Specialist training stage three

Region

2023 round posts

2024 round posts

2023 round posts

2024 round posts

East Midlands

18

20

24

12

East of England

22

26

6

14

Kent, Surrey and Sussex

23

18

5

4

London

58

52

3

4

North East

15

15

2

1

North West

37

41

2

10

South West

22

16

5

1

Thames Valley

10

16

3

5

Wessex

11

11

3

5

West Midlands

26

27

5

6

Yorkshire and the Humber

27

27

4

13

Total

269

269

62

75

Source: NHS England, available on the NHS.UK website, in an online only format.

The table presents the number of posts offered at both specialist training stages one and three. The latter meaning medical professionals will already have undertaken at least two years of relevant training or equivalent before entry to this later stage of the specialty training programme.

We are committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. This is central to the vision in our 10 Year Plan. 

We will ensure that the number of medical specialty training places meets the demands of the NHS in the future. NHS England will work with stakeholders to ensure that any growth is sustainable and focused in the service areas where need is greatest.

Medical Records
Asked by: Lord Kamall (Conservative - Life peer)
Monday 9th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the Single Patient Record, for which a request for information was published by NHS England on 29 April, will allow patients to see when and where their record has been accessed.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The single patient record will give staff in any provider access to the information they need to provide care, and would end the need for patients to have to repeat their medical history when interacting with the National Health Service.

We are currently in the early stages of considering the scope, and this includes what information patients will be able to see about when and where their record is accessed. Our engagement with the public identified the importance of there being an audit trail of access.

We will mandate its use by the NHS and social care, so that everyone has the opportunity to have a single patient record.

Medical Records
Asked by: Lord Kamall (Conservative - Life peer)
Monday 9th June 2025

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to mandate that a Single Patient Record, for which a request for information was published by NHS England on 29 April, will be required for every NHS patient.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The single patient record will give staff in any provider access to the information they need to provide care, and would end the need for patients to have to repeat their medical history when interacting with the National Health Service.

We are currently in the early stages of considering the scope, and this includes what information patients will be able to see about when and where their record is accessed. Our engagement with the public identified the importance of there being an audit trail of access.

We will mandate its use by the NHS and social care, so that everyone has the opportunity to have a single patient record.




Lord Kamall mentioned

Live Transcript

Note: Cited speaker in live transcript data may not always be accurate. Check video link to confirm.

30 Jun 2025, 6:11 p.m. - House of Lords
"noble Lord Kamall Lord Ahmad, in replying in 2022 to a question from "
Baroness Ludford (Liberal Democrat) - View Video - View Transcript
25 Jun 2025, 3:37 p.m. - House of Lords
" Following an answer to a written question by my noble friend Lord Kamall, data shows that last year "
Baroness Williams of Trafford (Conservative) - View Video - View Transcript


Parliamentary Debates
Perinatal Mental Health
15 speeches (1,374 words)
Wednesday 25th June 2025 - Lords Chamber
Department of Health and Social Care
Mentions:
1: Baroness Williams of Trafford (Con - Life peer) My Lords, following an Answer to a Written Question from my noble friend Lord Kamall, data shows that - Link to Speech

Mental Health Bill [ Lords ] (Eighth sitting)
66 speeches (17,764 words)
Committee stage: 8th sitting
Thursday 19th June 2025 - Public Bill Committees
Department of Health and Social Care
Mentions:
1: Stephen Kinnock (Lab - Aberafan Maesteg) Government amendments 26 to 29, which seek to overturn amendments tabled in the other place by Lord Kamall - Link to Speech

Mental Health Bill [ Lords ] (Seventh sitting)
45 speeches (12,660 words)
Committee stage: 7th sitting
Thursday 19th June 2025 - Public Bill Committees
Department of Health and Social Care
Mentions:
1: Stephen Kinnock (Lab - Aberafan Maesteg) In recognition of concerns expressed by Earl Howe and Lord Kamall, however, my noble Friend Baroness - Link to Speech

Mental Health Bill [ Lords ] (Sixth sitting)
144 speeches (31,099 words)
Committee stage: 6th sitting
Tuesday 17th June 2025 - Public Bill Committees
Department of Health and Social Care
Mentions:
1: Stephen Kinnock (Lab - Aberafan Maesteg) The clause seeks to overturn the previous amendment, tabled by Earl Howe and Lord Kamall. - Link to Speech
2: Gregory Stafford (Con - Farnham and Bordon) been mentioned, the clause was inserted in the House of Lords by my noble Friends Earl Howe and Lord Kamall - Link to Speech

Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025
18 speeches (4,078 words)
Tuesday 17th June 2025 - Grand Committee
Department of Health and Social Care
Mentions:
1: None The noble Lord, Lord Kamall, asked about the protection of patient data. - Link to Speech
2: None The noble Lord, Lord Kamall, expressed his disappointment that we are introducing model 1 only. - Link to Speech
3: Baroness Merron (Lab - Life peer) pharmacies are met and—to the point raised by a number of noble Lords, including the noble Lord, Lord Kamall—that - Link to Speech

Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025
15 speeches (3,222 words)
Tuesday 17th June 2025 - Grand Committee
Department of Health and Social Care
Mentions:
1: Baroness Merron (Lab - Life peer) As the noble Lord, Lord Kamall, said, that is so important to us as a country and an economy, as well - Link to Speech
2: Baroness Merron (Lab - Life peer) these services.I return to the point about small and medium-sized enterprises that the noble Lord, Lord Kamall - Link to Speech
3: Baroness Merron (Lab - Life peer) The gentle challenge from the noble Lord, Lord Kamall, was about whether the MHRA could manage it. - Link to Speech

Cardiovascular Illnesses
17 speeches (7,977 words)
Thursday 12th June 2025 - Grand Committee
Department of Health and Social Care
Mentions:
1: Baroness Merron (Lab - Life peer) This is a challenge on so many levels.I thank the noble Lords, Lord Kamall and Lord Weir, for understanding - Link to Speech

Mental Health Bill [ Lords ] (Third sitting)
53 speeches (12,417 words)
Committee stage: 3rd sitting
Thursday 12th June 2025 - Public Bill Committees
Department of Health and Social Care
Mentions:
1: Stephen Kinnock (Lab - Aberafan Maesteg) Furniss.Government amendments 26 to 29 seek to remove previous amendments to the clause tabled by Lord Kamall - Link to Speech



Bill Documents
Jun. 30 2025
HL Bill 89 Running list of amendments – 30 June 2025
Tobacco and Vapes Bill 2024-26
Amendment Paper

Found: LORD KAMALL EARL HOWE BARONESS GREY-THOMPSON _ After Clause 9, insert the following new Clause— “

Jun. 18 2025
HL Bill 89 Running list of amendments – 18 June 2025
Tobacco and Vapes Bill 2024-26
Amendment Paper

Found: LORD KAMALL EARL HOWE BARONESS GREY-THOMPSON _ After Clause 9, insert the following new Clause— “

Jun. 17 2025
HL Bill 89 Running list of amendments - 17 June 2025
Tobacco and Vapes Bill 2024-26
Amendment Paper

Found: LORD KAMALL EARL HOWE BARONESS GREY-THOMPSON _ After Clause 9, insert the following new Clause— “

Jun. 10 2025
Written evidence submitted by the Centre for Mental Health (MHB14)
Mental Health Bill [HL] 2024-26
Written evidence

Found: An amendment introduced by Lord Kamall in the House of Lords seeks to expand the category of ‘authorised

Jun. 09 2025
HL Bill 89 Running list of amendments - 9 June 2025
Tobacco and Vapes Bill 2024-26
Amendment Paper

Found: After Clause 9 LORD KAMALL EARL HOWE BARONESS GREY-THOMPSON _ After Clause 9, insert the following



APPG Publications

Commonwealth APPG
Tuesday 10th June 2025


Document: Guyana HC Meeting Minutes.pdf

Found: The Lord Kamall Iqbal Mohamed M.P. The Rt Hon. The Lord Northbrook The Rt Hon.

Commonwealth APPG
Tuesday 10th June 2025


Document: Sierra Leone HC Meeting - 04.09.2024.pdf

Found: M.P., as Chair of the Commonwealth APPG. 1.2 Andrew Rosindell M.P. conveyed the apologies of Lord Kamall

Commonwealth APPG
Tuesday 10th June 2025


Document: Rwanda HC Meeting Minutes.pdf

Found: The Lord Kamall of Edmonton H.E. Johnston Busingye, High Commissioner of Rwanda 1.

Switzerland and Liechtenstein APPG
Tuesday 10th June 2025


Document: Switzerland & Liechtenstein Inaugural Meeting 2024.pdf

Found: Apologies 2.1 Apologies given by: Lord Northbrook, Lord Kamall, Christine Jardine M.P., Sir Mark Hendrick

Commonwealth APPG
Tuesday 10th June 2025


Document: Commonwealth APPG - Dr Rakib Ehsan Meeting Minutes.pdf

Found: The Lord Kamall The Rt Hon. The Lord Northbrook The Rt Hon.

Commonwealth APPG
Tuesday 10th June 2025


Document: Commonwealth APPG Inaugural Meeting.pdf

Found: The Lord Kamall of Edmonton The Rt Hon.

Creative Health APPG
Wednesday 11th June 2025


Document: Minutes of meeting to discuss purpose of the APPG

Found: officers: Co-Chair: Dame Caroline Dinenage MP Vice-Chair: Lord Howarth of Newport Vice-Chair: Lord Kamall

Creative Health APPG
Wednesday 11th June 2025


Document: Minutes of the Inaugural General Meeting (November 26th 2024)

Found: Opher MP Co-Chair: Dame Caroline Dinenage MP Vice-Chair: Lord Howarth of Newport Vice-Chair: Lord Kamall

Digital Inclusion APPG
Wednesday 11th June 2025


Document: The Digital Inclusion APPG’s 2024 IGM

Found: Goudie ▪ Lord Truscott ▪ Baroness Lister ▪ Claire Hughes MP ▪ Lord Bishop ▪ Lord Lipsey ▪ Lord Kamall

Digital Inclusion APPG
Wednesday 11th June 2025


Document: minutes of the meeting

Found: Goudie ▪ Lord Truscott ▪ Baroness Lister ▪ Claire Hughes MP ▪ Lord Bishop ▪ Lord Lipsey ▪ Lord Kamall

Global Sexual and Reproductive Health and Rights APPG
Wednesday 11th June 2025


Document: Annual Report 2022-2023

Found: Hymenoplasty – 16th March 2022 The PUSS, Minister for Technology, Innovation and Life Sciences, Lord Kamall

Global Sexual and Reproductive Health and Rights APPG
Wednesday 11th June 2025


Document: Annual Report 2021-2022

Found: Lord Kamall, the PUSS for the Department of Health and Social Care, replied that in their VAWG strategy